U.S. Pharmacist Weekly News

U.S. Pharmacist PTA
September 27, 2017

Diabetes Medications Not Decreased in Medicare Patients With Low Blood Sugar
In a study focusing on 10 states, more than 10% of Medicare beneficiaries with diabetes had very low blood sugar, yet more than 85% of that group continued on the same or higher dosages of glucose-lowering medications. Find out why study authors consider this a critical problem.

Hormone Therapy Doesn’t Increase Mortality in Postmenopausal Women
Use of hormone therapy in postmenopausal women plummeted because of concerns about dangerous side effects. Yet a new study finds that women using either an estrogen-progestin combination or estrogen alone do not have higher mortality rates in general or from specific causes such as cardiovascular disease and cancer. Here are the details.

Levofloxacin Appears to Be Best Prophylactic for Pediatric
ALL Patients

Chemotherapy treatment-related infections can be killers for children with acute lymphoblastic leukemia. A new study identifies the best antibiotics to use prophylactically to avoid those infections, including deadly Clostridium difficile. Here is what researchers recommend.

Twice-Daily Aspirin Might Better Protect Diabetes Patients
From CVD

A once-daily aspirin might not be good enough to protect type 2 diabetes patients against cardiovascular disease (CVD). That is according to a new study which suggests that twice-daily dosing might be more effective. Here is why the researchers came to that conclusion.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App